Skip to content
  • Wednesday, 23 September 2026
  • 2:36 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk’s ziltivekimab misses Phase 3 primary endpoint
Laboratory Automation & Robotics

Novo Nordisk’s ziltivekimab misses Phase 3 primary endpoint

Lana Keisha Sep 23, 2026 0

In a significant setback for Novo Nordisk’s ambitions to diversify its cardiovascular pipeline, the company announced that its investigational human…

Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.Terray’s TerraBind Delivers 26x Faster Inference and Enhanced Accuracy, Challenging Diffusion-Based AI Models in Drug DiscoveryImmuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure ThroughputThese tiny holes could change how the world cleans water
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Breathtaking Discovery at UCSF Reveals Human Lungs Produce Blood Cells, Rewriting Medical TextbooksThe BioTechniques Image Competition 2026 Reveals Its Finalists Following Unprecedented Global Submissions and A Three-Way Tie For Tenth PlaceNovo Nordisk’s ziltivekimab misses Phase 3 primary endpointUnlocking the Biological Clock: How Immune System Failures Drive the Aging Process
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breathtaking Discovery at UCSF Reveals Human Lungs Produce Blood Cells, Rewriting Medical Textbooks
Dwi Wanna Sep 23, 2026
Biotech & Genetic Research
The BioTechniques Image Competition 2026 Reveals Its Finalists Following Unprecedented Global Submissions and A Three-Way Tie For Tenth Place
Jia Lissa Sep 23, 2026
Laboratory Automation & Robotics
Novo Nordisk’s ziltivekimab misses Phase 3 primary endpoint
Lana Keisha Sep 23, 2026
Neuroscience & Brain Research
Unlocking the Biological Clock: How Immune System Failures Drive the Aging Process
Rifan Muazin Sep 23, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ